Effects of Exercise in Patients With Repaired Coarctation of the Aorta (KOREKT)
Effects of Exercise on Select Indicators of Cardiovascular Health in Patients With Repaired Coarctation of the Aorta
This interventional study will investigate the effects of high-intensity interval training (HIIT) in adults with repaired coarctation of the aorta. Participants will be randomised into three groups: HIIT performed at home, HIIT performed in a supervised outpatient setting, or a control group receiving usual care. The two HIIT protocols will be identical in intensity and progression, individually prescribed for each patient.
The study will evaluate the effects of HIIT on exercise capacity, health-related quality of life, blood pressure response to exercise, and other select measures of cardiovascular health, including vascular stiffness and endothelial function. In addition, the study will examine the acute effects of a single exercise session on arterial stiffness.
Studienübersicht
Status
Bedingungen
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Ljubljana, Slowenien, 1000
- University Medical Centre Ljubljana
-
Maribor, Slowenien, 2000
- University Medical Centre Maribor
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- surgically repaired coarctation of the aorta,
- age at least 18 years, and
- signed informed consent form.
Exclusion Criteria:
- residual aortic stenosis (gradient across the narrowing >20 mmHg),
- presence of ascending aortic aneurysm,
- recent major cardiovascular event or other event requiring hospitalization (event less than 2 months before inclusion),
- unstable rhythm disturbances,
- unstable or low-threshold angina pectoris,
- NYHA class III or IV heart failure, and
- pregnancy.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Outpatient HIIT
Anticipated number of patients: 15. Participants will complete a structured high-intensity interval training (HIIT) programme performed in an outpatient setting. Intensity and progression are identical to the home-based HIIT arm. |
A structured exercise programme performed under direct supervision in an outpatient/clinical setting on a stationary bicycle or treadmill, consisting of 36 one-hour sessions over 2-4 months (approximately 2-3 sessions per week). Each session will comprise 8 five-minute intervals, each consisting of 2 minutes at 85-95% of the heart rate reached at VO2peak, followed by 3 minutes of active recovery. The interval block will be preceded by a 5-minute active warm-up and followed by a 5-minute active cool-down. Interval intensity will be individually determined for each patient. |
|
Experimental: Home-based HIIT
Anticipated number of patients: 15. Participants will complete a structured high-intensity interval training (HIIT) programme performed independently at home. Intensity and progression are identical to the outpatient HIIT arm. |
A structured exercise programme performed independently at home, consisting of 36 one-hour sessions over 2-4 months (approximately 2-3 sessions per week). Each session will comprise 8 five-minute intervals, each consisting of 2 minutes at 85-95% of the heart rate reached at VO2peak, followed by 3 minutes of active recovery. The interval block will be preceded by a 5-minute active warm-up and followed by a 5-minute active cool-down. Interval intensity will be individually determined for each patient. |
|
Kein Eingriff: Control (usual care)
Anticipated number of patients: 15. Participants will receive usual care, consisting of general counselling on physical activity performed at home, without a structured or supervised exercise training programme. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
VO2peak on cardiopulmonary exercise testing (CPET)
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Hypothesis: The outpatient high-intensity interval training (HIIT) programme improves aerobic capacity (measured by VO2peak) more than a home-based HIIT program or usual care.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Health-related quality of life
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Hypothesis: The outpatient high-intensity interval training (HIIT) programme improves health-related quality of life, assessed using the standardised SF-36 and EQ-5D questionnaires, more than a home-based HIIT programme or usual care.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Ratio of peak systolic blood pressure to peak workload (mmHg/W) on CPET
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Hypothesis: The outpatient high-intensity interval training (HIIT) programme reduces the ratio between peak systolic blood pressure and peak workload achieved during exercise testing more than a home-based HIIT programme or usual care.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Mean 24-hour systolic blood pressure
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of average systolic pressure during sleep and wakefulness, measured using 24-hour ambulatory blood pressure monitoring.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Echocardiographic parameters
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of standard echocardiographic measures of cardiac structure and function, including left ventricular global longitudinal strain (GLS).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Endothelial function of the right radial artery (flow-mediated dilation, FMD)
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Ultrasound assessment of endothelial function of the right radial artery, measured by flow-mediated dilation (FMD).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Heart rate variability
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of heart rate variability using high-resolution electrocardiography.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Biomarkers associated with vascular stiffness and atherosclerosis
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of circulating biomarkers associated with vascular stiffness and atherosclerosis, including atrial natriuretic peptide (ANP), growth/differentiation factor 15 (GDF-15), matrix metalloproteinase 1 (MMP-1), interleukin-33 receptor (IL-33/ST2), brain-derived neurotrophic factor (BDNF), galectin-3, myeloperoxidase, and tissue inhibitor of metalloproteinase 1 (TIMP-1).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Self-reported physical activity
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Self-reported physical activity level, assessed using the standardised International Physical Activity Questionnaire (IPAQ).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Body composition
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of body composition using bioelectrical impedance analysis.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Standard laboratory panel
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of standard laboratory parameters: electrolytes, renal function markers, liver function tests.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
NT-proBNP
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of NT-proBNP
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Extended lipid panel
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment extended lipid panel, including Lp(a).
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
|
Thyroid hormone level
Zeitfenster: At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Assessment of thyroid hormones.
|
At baseline and on follow-up assessment, with follow-up occurring within 3-12 months after baseline.
|
Mitarbeiter und Ermittler
Mitarbeiter
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 0120-101/2025-2711-4
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- ICF
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .